IH, T., Y, K., J, L., JM, L., J, K., SG, L., . . . HS, C. (2026). Targeting EHMT2 overcomes 5-fluorouracil resistance in colorectal cancer by modulating cell cycle and apoptosis. Signal transduction and targeted therapy, 11(1), . https://doi.org/10.1038/s41392-026-02692-7
Chicago Style (17th ed.) CitationIH, Tae, et al. "Targeting EHMT2 Overcomes 5-fluorouracil Resistance in Colorectal Cancer by Modulating Cell Cycle and Apoptosis." Signal Transduction and Targeted Therapy 11, no. 1 (2026). https://doi.org/10.1038/s41392-026-02692-7.
MLA (9th ed.) CitationIH, Tae, et al. "Targeting EHMT2 Overcomes 5-fluorouracil Resistance in Colorectal Cancer by Modulating Cell Cycle and Apoptosis." Signal Transduction and Targeted Therapy, vol. 11, no. 1, 2026, https://doi.org/10.1038/s41392-026-02692-7.